Related Experiment Videos

Current results from primary and secondary treatment of renal cell carcinoma

G P Murphy, R H Moore, G M Kenny

The Journal of Urology

|October 1, 1970

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Higher-dose and less frequent dendritic cell infusions with PSMA peptides in hormone-refractory metastatic prostate cancer patients.

The Prostate·2000

Follow-up ProstaScint scans verify detection of occult soft-tissue recurrence after failure of primary prostate cancer therapy.

The Prostate·2000

Follow-up evaluation of a phase II prostate cancer vaccine trial.

The Prostate·1999

GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial.

The Prostate·1999

Phase II prostate cancer vaccine trial: report of a study involving 37 patients with disease recurrence following primary treatment.

The Prostate·1999

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease.

The Prostate·1999

See all related articles